Novo Nordisk's next-gen obesity drug results a letdown for investors
  • Jun 22, 2025

Novo Nordisk's next-gen obesity drug results a letdown for investors

The province where COVID is free, but the vaccine isn’t
  • Jun 20, 2025

The province where COVID is free, but the vaccine isn’t

Islet cell transplant trial outcome 'major milestone' toward cure for diabetes
  •  —
  • Jun 20, 2025

Islet cell transplant trial outcome 'major milestone' toward cure for diabetes

How new vaccines could revolutionise our relationship with tuberculosis
  • Jun 20, 2025

How new vaccines could revolutionise our relationship with tuberculosis

People With Severe Diabetes Are Cured in Small Trial of New Drug
  •  —
  • Jun 20, 2025

People With Severe Diabetes Are Cured in Small Trial of New Drug

US Senate Democrats demand Kennedy explain canceling bird flu vaccine contract
  • Jun 20, 2025

US Senate Democrats demand Kennedy explain canceling bird flu vaccine contract

Here’s what’s happening in Trump-land (It’s bad)
  • Jun 20, 2025

Here’s what’s happening in Trump-land (It’s bad)

B.C. government won't fund drug for rare disease for nine-year-old girl
  • Jun 19, 2025

B.C. government won't fund drug for rare disease for nine-year-old girl

The world's only twice-a-year shot to prevent HIV could stop transmission — if people can get it
  • Jun 19, 2025

The world's only twice-a-year shot to prevent HIV could stop transmission — if people can get it

Nicole Verdun, top gene therapy regulator, is out at FDA
  • Jun 19, 2025

Nicole Verdun, top gene therapy regulator, is out at FDA

Health Canada approves Novartis' KISQALI® for HR+/HER2- early breast cancer patients at high risk of recurrence
  • Jun 19, 2025

Health Canada approves Novartis' KISQALI® for HR+/HER2- early breast cancer patients at high risk of recurrence

FDA to offer faster drug reviews to companies promoting 'national priorities'
  • Jun 17, 2025

FDA to offer faster drug reviews to companies promoting 'national priorities'

B.C. Supreme Court certifies class-action suit against McKinsey for alleged opioid promotion
  • Jun 17, 2025

B.C. Supreme Court certifies class-action suit against McKinsey for alleged opioid promotion

'HIV-ending' drug could be made for just $25 per patient a year, say researchers
  • Jun 17, 2025

'HIV-ending' drug could be made for just $25 per patient a year, say researchers

PMPRB report reviews potential impact of new medicines on the Canadian market
  • Jun 17, 2025

PMPRB report reviews potential impact of new medicines on the Canadian market

Biosimilar Update: Health Canada Reconsiders Requirement for Comparative Clinical Trials
  • Jun 17, 2025

Biosimilar Update: Health Canada Reconsiders Requirement for Comparative Clinical Trials

Second patient death reported with gene therapy for muscular dystrophy
  • Jun 16, 2025

Second patient death reported with gene therapy for muscular dystrophy

Ancient miasma theory may help explain Health Secretary Robert F. Kennedy Jr.'s vaccine moves
  • Jun 14, 2025

Ancient miasma theory may help explain Health Secretary Robert F. Kennedy Jr.'s vaccine moves

Independent US vaccine body is planned after RFK Jr's mass firing of CDC advisory panel
  • Jun 14, 2025

Independent US vaccine body is planned after RFK Jr's mass firing of CDC advisory panel

A silent virus might be causing major diseases
  • Jun 13, 2025

A silent virus might be causing major diseases

Experts fear upheaval in the U.S. could fuel vaccine distrust in Canada
  • Jun 13, 2025

Experts fear upheaval in the U.S. could fuel vaccine distrust in Canada

FDA approves Moderna RSV vaccine use for people aged 18 to 59
  • Jun 13, 2025

FDA approves Moderna RSV vaccine use for people aged 18 to 59

Blood cancer patients in England first in world to be offered 'Trojan horse' drug
  • Jun 13, 2025

Blood cancer patients in England first in world to be offered 'Trojan horse' drug

Shining a Light on the World of Tiny Proteins
  •  —
  • Jun 13, 2025

Shining a Light on the World of Tiny Proteins

Check out our newsletter, The Weekly Dose – it's a handpicked roundup of the most important news from the week.  Subscribe